Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025 and Dec 2025.
- Largest single sale: $501K (12,048 shares) of Kiniksa Pharmaceuticals International, plc on Dec 15, 2025. Filing
- Last sale before this period: Oct 14, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, plc (KNSA) | Chief Strategy Officer | Jun 21, 2021 | Apr 8, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Apr 7, 2026, Kiniksa Pharmaceuticals International, plc: 2,726 shares vested; 846 shares withheld by the company for taxes. 1 filing: 1
- Apr 1, 2026, Kiniksa Pharmaceuticals International, plc: 5,975 shares vested; 1,756 shares withheld by the company for taxes. 1 filing: 1
- Jan 15, 2026, Kiniksa Pharmaceuticals International, plc: 365 shares awarded. 1 filing: 1
- Dec 15, 2025, Kiniksa Pharmaceuticals International, plc: sold 12,048 shares for $501K, under a disclosed plan; 6,000 shares vested or acquired by exercising options. 1 filing: 1
- Nov 26, 2025, Kiniksa Pharmaceuticals International, plc: sold 200 shares for $9K, under a disclosed plan; 200 shares vested or acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.